Morgenthaler Ventures
VC Fund
Menlo Park, United States
Morgenthaler Ventures is a VC fund in Menlo Park focused on Health Care and Biotechnology. Morgenthaler Ventures has been in the venture capital business for more than 45 years, steadily investing through every market cycle. Select past and present portfolio companies in the IT space include: Evernote, Lending Club, Siri, MuleSoft, Practice Fusion, Adara Media, Check, Doximity, PeopleMatter, Socrata, NuoDB, Jaspersoft, VoltageSecurity, Rhythm NewMedia, Nominum, Wize Commerce (NexTag) and back in the day, Apple.
- Total investments:
- 232
- Last investment:
- Lead investor:
- 15%
- Fund size:
- $400M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Morgenthaler Ventures invests in
Stages Morgenthaler Ventures invests in
Countries Morgenthaler Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 16 contacts → | |||
Investment Focus
Industry
- Health Care 41 (18%)
- Biotechnology 29 (13%)
- Medical 25 (11%)
- Medical Device 21 (9%)
- Manufacturing 20 (9%)
Stage
- Series B 51 (22%)
- Series A 41 (18%)
- Series C 39 (17%)
- Funding Round 37 (16%)
- Series D 23 (10%)
Country
- United States 109 (47%)
- Canada 1 (0%)
- France 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bob Pavey
Partner
|
Partner | Total investments: 14 | Find email | |
Gary Morgenthaler
Partner
|
Partner | Total investments: 20 | Find email | |
Hank Plain
Partner
|
Partner | Total investments: 20 | Find email | |
Ralph Christoffersen
Partner
|
Partner | Total investments: 13 | Find email | |
Bridget Odorcic
Operations & Fund Compliance Manager
|
Operations & Fund Compliance Manager | Total investments: 0 | Find email | |
| See all 16 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $115M / Series D / Aug 11, 2025 | ||
| Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis. | $61M / Series D / Aug 13, 2024 | ||
| Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain. | $50M / Series G / Mar 27, 2023 | ||
| SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $80M / Series C / Jan 19, 2023 | ||
| Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis. | $40M / Series C / Aug 16, 2022 | ||
| SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $64M / Series B / Jan 27, 2021 | ||
| Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain. | $70M / Series F / Oct 29, 2020 | ||
| SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $15.7M / Venture - Series Unknown / Sep 18, 2019 | ||
| Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease.It was founded in 2008and headquartered in Minneapolis, Minnesota. | $79M / Series E / Feb 11, 2019 | ||
| NuoDB’s distributed SQL database for cloud applications helps customers get applications to market faster and reduce their total cost of ownership. Software vendors and e-commerce companies rely on NuoDB to obtain the combination of scale-out simplicity, elasticity, and continuous availability that cloud applications require, with the transactionalconsistency and durability that databases of record demand.As a result, customers can capitalize on modern technologies such as cloud computing and containerization to ensure their applications are ready for today’s evolving expectations, as well as any future requirements.NuoDB is headquartered in Cambridge, Massachusetts, USA, with offices in Dublin, London, and Sofia. | $30.6M / Dec 31, 2018 | ||
| See all 232 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Morgenthaler Ventures invest in?
Morgenthaler Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series A stage. Most of the 232 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Morgenthaler Ventures?
Public channels for Morgenthaler Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Morgenthaler Ventures?
The team at Morgenthaler Ventures includes Bob Pavey (Partner), Gary Morgenthaler (Partner) and Hank Plain (Partner), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
